Bingchuan Wei discusses the latest trends in chromatography.
The drug developer has built its portfolio with this in mind, through ongoing investment in tumor-targeted cell-killing treatments such as antibody–drug conjugates (ADCs) and radio-conjugates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback